Eli Lilly’s retatrutide could present a “differentiated option” for patients with type 2 diabetes who want to control their blood sugar and achieve maximal weight loss,...
The US Food and Drug Administration (FDA) has granted Fast Track Designation to a treatment for the rare paediatric disease late-infantile neuronal ceroid lipofuscinosis (LINCL/CLN2 disease). ...
A new initiative is set to generate and model biological data at the trillion-gene scale, paving the way to scale AI-designed therapeutics. The Trillion Gene Atlas,...
Biotechnology company Aptamer Group has launched a radiopharmaceutical programme to develop new therapeutic targets. The programme, launched in collaboration with Radiopharmium, will look to develop three strategic...
The new issue of DDW is now on its way to subscribers and available to read online. The Spring issue explores the next phase of obesity medications...
Nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore.
Nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.
Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem.